RxDoctor Payments Data

Joel Cohen, MD

MOHS-Micrographic Surgery · Greenwood Village, CONPI 1386667871

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (50.9%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 21 manufacturers reported payments, led by Galderma Laboratories, L.p. at 52.8% of the total. Reporting peaked in 2022 at $94,228 and has fallen 52.3% since, to $44,983 in 2025. Among mohs-micrographic surgery clinicians in CO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$425,552in general payments, 2019–2025

Across 434 payments — averaging $980.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Galderma Laboratories, L.p.$225K
  • AbbVie$90K
  • Biofrontera Inc.$52K
  • Merz North America, Inc.$21K
  • Solta Medical, A Division Of Bausch Health US, LLC$10K
  • Endo Pharmaceuticals Inc.$10K
  • plus $17K from 15 others
$1,613,931in research payments, 2019–2025

Across 137 payments — averaging $11,781 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • AbbVie$562K
  • Biofrontera Inc.$412K
  • Biofrontera Bioscience GmbH$315K
  • Merz North America, Inc.$228K
  • Endo Pharmaceuticals Inc.$59K
  • Pfizer$16K
  • plus $21K from 2 others

What the payments were for

  • Consulting fees$216,47451%
  • Speaking & faculty fees$152,74036%
  • Grants$13,8673%
  • Travel & lodging$26,8676%
  • Food & beverage$14,6033%
  • Education$1,0020%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$425,552 in reported general payments places this provider in the 95th percentile of 37 mohs-micrographic surgery providers in Colorado.

See all mohs-micrographic surgery providers in Colorado

Medicare billing

Part B allowed, 2024
$78,709
Medicare patients
102
Services billed
2,350

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
ValacyclovirValacyclovir Hcl45$767
Imiquimod16$623

Paid to pharmacies, not to this prescriber.

Other mohs-micrographic surgery in Greenwood Village

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →